Io Biotech Inc (IOBTQ)

$0.01 -0.04 (-82.92%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 34,074,199
Avg Vol 14,870,131
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 1%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to...

Industry: Biotechnology
Sector: Healthcare
Phone: 45 70 70 29 80
Address:
Ole MaalOees Vej 3, Copenhagen N, Copenhagen, Denmark
here4thedinero
here4thedinero May. 13 at 2:48 PM
$IOBTQ REPL is up 270% since i bought this junk. I debated on the two of them and decided to chanve a BK. FML.
1 · Reply
US_Bull
US_Bull May. 13 at 12:06 PM
$IOBTQ (2/2) The risk is the below anyway if my thesis is all wrong then I will just chalk it up to experience and use it as tax write off. Always do your OWN DD!!
1 · Reply
US_Bull
US_Bull May. 13 at 12:03 PM
$IOBTQ (1/2)
0 · Reply
US_Bull
US_Bull May. 13 at 11:44 AM
$IOBTQ $ADAPY
0 · Reply
US_Bull
US_Bull May. 13 at 11:36 AM
$IOBTQ They have 17 granted US patents and foreign patents with earliest patent expiration in 2032. This could be the pharma turnaround story of the year if a mid-sized or smaller sized pharma company revived them. Haven't sold a single share still long and strong on my 1.2 million shares.
0 · Reply
US_Bull
US_Bull May. 13 at 11:34 AM
$IOBTQ If someone was smart they would buy the assets and take Cylembio through the regulatory path now that Makarty is gone! Cylembio has potential significantly greater than checkpoint inhibitors alone and their manufacturing is also way less costly than mRNA vaccines!
0 · Reply
US_Bull
US_Bull May. 9 at 12:37 PM
$IOBTQ I am still hoping a smaller to mid pharma will pick up all the assets! Company has tons of granted US patents and 4 assets in the clinic, FDA trials and protocols.
0 · Reply
US_Bull
US_Bull May. 8 at 9:57 PM
$IOBTQ Exactly my thinking with Makary gone probably why it finished green today. The main asset just barely missed statistical difference no doubt the drug works blocking 2 different targets. I am still long haven't sold any shares.
0 · Reply
badprecog
badprecog May. 8 at 6:00 PM
$IOBTQ With Makary gone and a true reformer likely coming in whoever buys this is likely picking up a drug that might not need a new trial. What a total ___ job.
0 · Reply
Jtlo
Jtlo May. 8 at 5:08 PM
$IOBTQ $KALA hello
0 · Reply
Latest News on IOBTQ
No data available.
here4thedinero
here4thedinero May. 13 at 2:48 PM
$IOBTQ REPL is up 270% since i bought this junk. I debated on the two of them and decided to chanve a BK. FML.
1 · Reply
US_Bull
US_Bull May. 13 at 12:06 PM
$IOBTQ (2/2) The risk is the below anyway if my thesis is all wrong then I will just chalk it up to experience and use it as tax write off. Always do your OWN DD!!
1 · Reply
US_Bull
US_Bull May. 13 at 12:03 PM
$IOBTQ (1/2)
0 · Reply
US_Bull
US_Bull May. 13 at 11:44 AM
$IOBTQ $ADAPY
0 · Reply
US_Bull
US_Bull May. 13 at 11:36 AM
$IOBTQ They have 17 granted US patents and foreign patents with earliest patent expiration in 2032. This could be the pharma turnaround story of the year if a mid-sized or smaller sized pharma company revived them. Haven't sold a single share still long and strong on my 1.2 million shares.
0 · Reply
US_Bull
US_Bull May. 13 at 11:34 AM
$IOBTQ If someone was smart they would buy the assets and take Cylembio through the regulatory path now that Makarty is gone! Cylembio has potential significantly greater than checkpoint inhibitors alone and their manufacturing is also way less costly than mRNA vaccines!
0 · Reply
US_Bull
US_Bull May. 9 at 12:37 PM
$IOBTQ I am still hoping a smaller to mid pharma will pick up all the assets! Company has tons of granted US patents and 4 assets in the clinic, FDA trials and protocols.
0 · Reply
US_Bull
US_Bull May. 8 at 9:57 PM
$IOBTQ Exactly my thinking with Makary gone probably why it finished green today. The main asset just barely missed statistical difference no doubt the drug works blocking 2 different targets. I am still long haven't sold any shares.
0 · Reply
badprecog
badprecog May. 8 at 6:00 PM
$IOBTQ With Makary gone and a true reformer likely coming in whoever buys this is likely picking up a drug that might not need a new trial. What a total ___ job.
0 · Reply
Jtlo
Jtlo May. 8 at 5:08 PM
$IOBTQ $KALA hello
0 · Reply
US_Bull
US_Bull May. 6 at 8:59 PM
$IOBTQ Worst case scenario it will be my tax write off for the calendar year.
1 · Reply
US_Bull
US_Bull May. 6 at 8:58 PM
$IOBTQ Admittedly not looking good currently, but I am holding on maybe as the only retail left holding lol.
1 · Reply
US_Bull
US_Bull May. 5 at 10:49 AM
$IOBTQ Those that are bearish and state the obvious that they filed for Ch. 7 you don't understand how the process works and that you can still make money in the meantime. The Ch. 7 BR does not end in a day lol. It takes at a bare minimum a few months, let alone with complex pharma companies like IOBT that has 4 assets and tons of IP. Those assets need to be sold. Again the stock doesn't just magically drop to 0$ it still trades for months. I have bee nwatching how the stock trades vs. REPL and they trade inverse of one another. When people realize that REPL is done (should have been by now after 2 CRLS) and they stop feeding the hopium it will crash hard. It will catapult IOBT. Haven't sold a single of my 1.2 million shares I am long on IOBT. Those assets are worth something.
1 · Reply
pennylotto
pennylotto May. 4 at 5:19 PM
$IOBTQ Anyone seeing any relevant news?
1 · Reply
Stockinvestor73
Stockinvestor73 Apr. 28 at 8:05 PM
$IOBTQ
0 · Reply
US_Bull
US_Bull Apr. 24 at 3:52 PM
$IOBTQ Yup. It has started its ascent! REPL needs to really crash hard and it will when people realize it is nothing but liquidity exit for tutes giving their bag onto retail.
0 · Reply
Stockinvestor73
Stockinvestor73 Apr. 23 at 7:21 PM
$IOBTQ looks like a major trainwreck
1 · Reply
Joijoi
Joijoi Apr. 23 at 6:37 PM
$IOBTQ why this drop today. Any news ???
2 · Reply
US_Bull
US_Bull Apr. 22 at 4:49 PM
$IOBTQ It is phenomenal how they just won't let $REPL (bearish on REPL) go even though path forward has not changed since the CRL and how it trades the exact inverse to IOVA and $IOBTQ
0 · Reply
NetworkNewsWire
NetworkNewsWire Apr. 22 at 2:02 PM
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition $OTLC $AUTL $WVE $IOBTQ $RHHBY https://ibn.fm/4yuU5
0 · Reply
US_Bull
US_Bull Apr. 21 at 5:12 PM
$REPL $IOBTQ Very simply the more REPL crashes the higher IOBT goes up. Thesis is intact.
0 · Reply
US_Bull
US_Bull Apr. 21 at 1:47 PM
$IOBTQ Thesis was point on!!! REPL tanking finally after a week momentum regained for IOBT.
1 · Reply